Clinical predictors of SARS‐CoV‐2 neutralizing antibody titers in COVID‐19 convalescents: Implications for convalescent plasma donor recruitment
Authors:
Open Access
- 29 March 2021
- journal article
- review article
- Published by Wiley in European Journal of Haematology
- Vol. 107 (1) , 24-28
Abstract
While COVID‐19 convalescent plasma (CCP) efficacy is still under investigation in randomized controlled trials (RCT), CCP collections continue worldwide with largely variable criteria. Since it is well known that only a minority of patients develop high‐titer neutralizing antibodies (nAb), as assessed by the viral neutralization tests (VNT), strategies to maximize cost‐effectiveness of CCP collection are urgently needed. A growing amount of the population is having exposure to the virus and is hence becoming a candidate CCP donor. Laboratory screening with high‐throughput serology has good correlations with the VNT titer, but upstream screening using clinical surrogates would be advisable. We review here the existing literature on clinical predictors of high‐titer nAb. Older age, male sex, and hospitalization are the main proxies of high VNT and should drive CCP donor recruitment.Keywords
This publication has 31 references indexed in Scilit:
- Characterization of100sequentialSARS-CoV-2convalescent plasma donationsTransfusion, 2021
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationJournal of Clinical Investigation, 2020
- SARS‐CoV‐2 neutralization and serology testing of COVID‐19 convalescent plasma from donors with nonsevere diseaseTransfusion, 2020
- SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patientsJournal of Clinical Virology, 2020
- Kinetics of viral load and antibody response in relation to COVID-19 severityJournal of Clinical Investigation, 2020
- Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapyReviews in Medical Virology, 2020
- Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor programTransfusion, 2020
- SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma DonorsThe Journal of Infectious Diseases, 2020
- Safety UpdateMayo Clinic Proceedings, 2020
- Considering how biological sex impacts immune responses and COVID-19 outcomesNature Reviews Immunology, 2020